Report highlights many benefits of Omega-3s

15 April 2007

The current edition of the electronic newsletter Fats of Life, sponsored by Dutch pharmaceutical and nutritional ingredients firm DSM, features data that indicates that long-chain omega-3 polyunsaturated fatty acids are essential for infant and adult brain development. The article, which also features in the polyunsaturated fatty acid (PUFA) newsletter, goes on to suggest that omega-3s may protect against certain types of heart disease and cancer.

As Joyce Nettleton, editor of the Fats of Life, explained, "recent evidence about the effects of these marine omega-3s in different conditions- young children, young adults with certain risky behaviors and older people with heart disease - points to suboptimal health outcomes at different stages of life when [levels of] these fatty acids are insufficient."

Mounting clinical evidence supports use of Omega-3s

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight